Deschloro Vemurafenib
| Product Name | Deschloro Vemurafenib |
|---|---|
| Alternate Names | Vemurafenib Impurities, Impurities of Vemurafenib |
| CAT No. | CS-O-10696 |
| CAS No. | 918504-63-9 |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 455.48 g/mol |
| Mol. For. | C₂₃H₁₉F₂N₃O₃S |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Vemurafenib |
| Purity | >98% |
| Therapeutic | Anti-Cancer / Oncology |
| Smileys | O=C(C(C(F)=CC=C1N[S](CCC)(=O)=O)=C1F)C2=CNC3=NC=C(C4=CC=CC=C4)C=C23 |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Deschloro Vemurafenib is a chemical substance that is primarily used in the treatment of melanoma, a type of skin cancer that is often caused by exposure to UV radiation. It belongs to a class of drugs known as BRAF inhibitors, which work by blocking the activity of a protein called BRAF that is involved in the growth and spread of cancer cells.
Chemically, Deschloro Vemurafenib is a small molecule that has a molecular weight of 485.95 g/mol and a chemical formula of C23H18ClF2N3O3. It is a white to off-white powder that is soluble in organic solvents such as methanol and ethanol but poorly soluble in water.
The recommended dosage of Deschloro Vemurafenib varies depending on the patient's age, weight, and medical condition. It is typically administered orally in the form of tablets or capsules and should be taken with food to increase its absorption.
Like all drugs, Deschloro Vemurafenib may cause some side effects, such as nausea, vomiting, diarrhea, headache, and fatigue. It may also increase the risk of developing other types of cancer, such as squamous cell carcinoma of the skin.
In conclusion, Deschloro Vemurafenib is a potent BRAF inhibitor that is used to treat melanoma. Its chemical properties and recommended dosage make it an effective treatment option, although it may cause some side effects and increase the risk of developing other types of cancer.
Get an Instant Quote
Related Compounds
N-Hydroxymethyl Vemurafenib | N-Formyl Vemurafenib | Deschlorophenyl Vemurafenib |